Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | RAB9A | P51151 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | BRD4 | O60885 | 1/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | MB | P02144 | 1/20 | 0.57 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9771269 | 0.98 | KMT2A (0.68) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL4748577 | 0.83 | CYP2C9 (0.56) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL861674 | 0.82 | SMN1; SMN2 (0.84) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL17792928 | 0.81 | RXFP1 (0.57) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL8319331 | 0.81 | CYP2C9 (0.50) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL599684 | 0.81 | KMT2A (0.73) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL31193370 | 0.81 | MAPT (0.68) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL1542345 | 0.80 | ALDH1A1 (0.58) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL14508151 | 0.79 | ALDH1A1 (0.46) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL17055695 | 0.79 | SMN1; SMN2 (0.44) | KMT2AMEN1SMN1; SMN2ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116396313-A | Alkenyl borate, and preparation method and application thereof | 中山大学 | 2023-07-07 | — | — | CN | claimed |
| US-9868820-B2 | Polyarylene materials | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2018-01-16 | — | — | US | claimed |
| EP-4663628-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Samjin Pharmaceutical Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| US-12379660-B2 | Adhesion promoting photoresist underlayer composition | DUPONT ELECTRONIC MATERIALS INTERNATIONAL, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250136580-A1 | INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-05-01 | — | — | US | disclosed |
| WO-2025048243-A1 | NOVEL ISOXAZOLE COMPOUND AS TM4SF5-SPECIFIC INHIBITOR AND USE THEREOF | 서울대학교산학협력단 | 2025-03-06 | — | — | WO | disclosed |
| WO-2024166024-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2024-08-15 | — | — | WO | disclosed |
| CN-116396313-A | Alkenyl borate, and preparation method and application thereof | 中山大学 | 2023-07-07 | — | — | CN | disclosed |
| US-20220356182-A1 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | MERCK SHARP & DOHME CORP. (US) | 2022-11-10 | — | — | US | disclosed |
| US-20220356182-A1 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | MERCK SHARP & DOHME CORP. (US) | 2022-11-10 | — | — | US | disclosed |
| CN-114671874-A | Theophylline acetic acid derivative with anti-tumor activity and preparation method and application thereof | 济南爱思医药科技有限公司 | 2022-06-28 | — | — | CN | disclosed |
| EP-0200011-B1 | HEAT-DEVELOPABLE LIGHT-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1989-09-13 | — | — | EP | disclosed |
| US-4857961-A | Image forming apparatus | FUJI PHOTO FILM CO., LTD. (JP) | 1989-08-15 | — | — | US | disclosed |
| US-4782004-A | PHENOLIC SULFONAMIDE OR POLYMER WITH PHENOL AND/OR SULFONAMIDE GROUPS | FUJI PHOTO FILM CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| US-4775613-A | CONTAINING ACETYLENE SILVER COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1988-10-04 | — | — | US | disclosed |
| US-4761361-A | SILVER HALIDE EMULSIONS | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-02 | — | — | US | disclosed |
| US-4745043-A | PHOTOGRAPHY, SILVER HALIDE EMULSIONS | FUJI PHOTO FILM CO., LTD. (JP) | 1988-05-17 | — | — | US | disclosed |
| US-4740445-A | COMPLEXING METAL COMPOUNDS WITH PYRIDINE OR QUINOLINE RING HAVING AMINE SALT FUNCTION | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-26 | — | — | US | disclosed |
| EP-0210660-A2 | Image forming process | FUJI PHOTO FILM CO., LTD. (JP) | 1987-02-04 | — | — | EP | disclosed |
| EP-0200011-A1 | Heat-developable light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1986-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220356182-A1 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | HAVCR2, HCCS, EIF2AK2 | KMT2A 4309/4885MEN1 4685/4885SMN1; SMN2 4833/4885 |
| US-20250136580-A1 | INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE | MELK, HIPK1, HIPK3 | KMT2A 1029/4885MEN1 3710/4885SMN1; SMN2 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.